海尔生物：10月30日召开董事会会议

Group 1 - Haier Biomedical held its third board meeting on October 30, 2025, to discuss the proposal for accounts receivable factoring business and related transactions [1] - For the year 2024, Haier Biomedical's revenue composition is 99.57% from medical devices and 0.43% from other businesses [1] - As of the report, Haier Biomedical has a market capitalization of 10.9 billion yuan [1]